focused on the evaluation of postoperative management of patients with pheochromocytoma assessing hemodynamic ... surgical difficulty of treatment using RPLA (Retroperitoneal Laparoscopic ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

The 2004 WHO classification of endocrine tumors defines pheochromocytoma as a tumor arising from catecholamine-producing chromaffin cells in the adrenal medulla -- an intra-adrenal paraganglioma.

This summary explores recent research comparing laparoscopic and robotic techniques for adrenalectomy, highlighting their effectiveness, safety, and overall outcomes. Recent studies have focused ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

The obligatory adrenal insufficiency caused by surgery must be adequately substituted with hydrocortisone; additional fludrocortisone might also be necessary with high doses of mitotane.

Figure 1. Operation room setting during bilateral laparoscopic adrenalectomy through flank approach in sternal recumbency in an Australian Shepherd dog with HC. In the picture, right LA is in progress ...

A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...